MSF challenges Pfizer’s pneumonia vaccine patent in India
March 11, 2016Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, Prevnar 13, pneumonia vaccine
The charity Médecins Sans Frontières (MSF) has formally opposed Pfizer’s bid to obtain a patent for the pneumonia vaccine PCV13, …
Spanish firm Grifols to spend a total of $360 million on four new plants
March 11, 2016Manufacturing and Production, Medical Communications grifols, manufacturing, pharma, plasma, production
Grifols (Nasdaq: GRFS) said it will invest a total of $360 million over 2016-2021, to increase the plasma fractionation capacity …
Dr. Reddy’s, TR-Pharm to collaborate on 3 biosimilars in Turkey
March 11, 2016Manufacturing and Production, Medical Communications, Sales and Marketing Dr Reddy's Laboratories, TR-Pharm, biosimilar, generics, marketing collaboration
Three biosimilar products by the Indian generics company Dr. Reddy’s will be marketed by TR-Pharm in Turkey, the companies said …
Novartis seeks expanded Arzerra use in US
March 11, 2016Research and Development Arzerra, CLL, FDA, Genmab, Novartis
Novartis has submitted a supplemental Biologics License Application (sBLA) to the US FDA for the use of Arzerra (ofatumumab) in …
Spark Therapeutics buys Genable Tech for $6 million in cash and stock deal
March 11, 2016Business Services, Medical Communications Genable Technologies, Spark Therapeutics, cash & stock, genetic technologies, merger & acquisitions
Spark Therapeutics (Nasdaq: ONCE) said it has acquired Ireland-based Genable Technologies, a privately-held gene therapy firm for $6 million in a cash …
US FDA sets April 25 date to review Sarepta’s DMD drug, shares jump
March 11, 2016Medical Communications, Research and Development Duchenne Muscular Dystrophy, Eteplirsen, Sarepta Therapeutics, US FDA
Shares in US-based Sarepta Therapeutics (Nasdaq: SRPT) jumped nearly 15% Thursday after the US Food and Drug Administration (FDA) said it …
US Congress Committee pressures Valeant to produce drug pricing documents
March 11, 2016Medical Communications, Sales and Marketing Drug pricing, Michael Pearson, Valeant
Valeant’s tough month continued yesterday, with a US congressional committee pressuring the company to explain why it has not produced …
Teva funds research to protect fertility in women diagnosed with cancer
March 11, 2016Business Services, Research and Development Cancer, IVF Worldwide, Teva, fertility, radiotherapy
Israeli generics giant Teva has announced it will support IVF-Worldwide with a research grant to improve knowledge of fertility preservation …
Alphabet’s life science unit makes device to aid gathering of health data for research
March 11, 2016Medical Communications, Research and Development Alphabet, Connectivity Bridge, Verily, google, life sciences
Verily, the life sciences unit of Alphabet, has unveiled Connectivity Bridge, a device designed to sync and collect medical information for …
Sanofi says its RA drug bested Humira in Phase III study
March 11, 2016Medical Communications, Research and Development Humira, Regeneron, Sanofi
Sanofi and its R&D arm Regeneron Pharmaceuticals say their monoclonal antibody sarilumab outperformed AbbVie’s Humira in treating the symptoms of …
Vericel stock nearly doubles as heart failure drug meets primary endpoint in mid-stage trial
March 11, 2016Medical Communications, Research and Development
Shares in US-based biotech firm Vericel nearly doubled on the Nasdaq on Thursday as the company reported its heart failure …
Novartis to unify Fougera’s US manufacturing plants
March 11, 2016Manufacturing and Production, Medical Communications Fougera, Novartis, Sandoz, manufacturing
Novartis is planning to unify the two manufacturing plants used by Sandoz unit Fougera Pharmaceuticals in the US, expanding and …
FDA grants approval for first generic version of Viagra
March 10, 2016Manufacturing and Production, Research and Development, Sales and Marketing FDA, Pfizer, Teva, erectile dysfunction, generic, viagra
The US Food and Drug Administration (FDA) has granted approval to the first generic version of Pfizer’s blockbuster erectile dysfunction …
Two-drug combo shown to significantly shrink breast cancer in days
March 10, 2016Medical Communications, Research and Development GSK, Herceptin, Novartis, Roche, Tyverb
Results of a clinical trial have revealed that Novartis’ Tyverb (lapatinib), in combination with Roche’s Herceptin (trastuzumab), can significantly shrink …
Teva issues US recall of amikacin sulfate injection due to glass identified in vials
March 10, 2016Manufacturing and Production Teva, amikacin sulfate, glass, recall
Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP vials due to the potential …
New manufacturing boss for MSD
March 10, 2016Manufacturing and Production, Medical Communications MSD, manufacturing
MSD has appointed Sanat Chattopadhyay president of the Merck Manufacturing Division (MMD) and an executive vice president of the company. …
Researcher develops strategy to identify antimicrobial drugs that tackle drug-resistant pathogens
March 10, 2016Manufacturing and Production, Research and Development anitmicrobial, drug discovery, drug repurposing, mohamed seleem, purdue university
A researcher from Purdue University’s College of Veterinary Medicine has developed a novel method of repurposing drugs to act as …
Amarin wins case against FDA to promote Vascepa for off-label uses
March 10, 2016Medical Communications, Research and Development, Sales and Marketing Amarin, FDA, first amendment, off label, vascepa
Amarin has announced a settlement with the US Food and Drug Administration (FDA) that resolves the dispute over the Irish-based …
Lupin completes acquisition of US-based Gavis Pharmaceuticals
March 10, 2016Research and Development, Sales and Marketing FDA, Gavis, Lupin, acquisition, generics
Indian drug manufacturer Lupin has announced the completion of its acquisition of New Jersey-based pharmaceutical firm, Gavis, in a deal …
Survey reveals patient groups’ views on pharma industry
March 10, 2016Research and Development, Sales and Marketing patientview
A new report, published by research and consultancy group PatientView, has revealed the attitude of more than 1,000 patient groups …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
